• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDZ 蛋白酶 HTRA1 降解淀粉样纤维的决定因素。

Determinants of amyloid fibril degradation by the PDZ protease HTRA1.

机构信息

Centre of Medical Biotechnology, Faculty of Biology, University Duisburg-Essen, Essen, Germany.

Department of Structural Biochemistry, Max Planck Institute Molecular Physiology, Dortmund, Germany.

出版信息

Nat Chem Biol. 2015 Nov;11(11):862-9. doi: 10.1038/nchembio.1931. Epub 2015 Oct 5.

DOI:10.1038/nchembio.1931
PMID:26436840
Abstract

Excessive aggregation of proteins has a major impact on cell fate and is a hallmark of amyloid diseases in humans. To resolve insoluble deposits and to maintain protein homeostasis, all cells use dedicated protein disaggregation, protein folding and protein degradation factors. Despite intense recent research, the underlying mechanisms controlling this key metabolic event are not well understood. Here, we analyzed how a single factor, the highly conserved serine protease HTRA1, degrades amyloid fibrils in an ATP-independent manner. This PDZ protease solubilizes protein fibrils and disintegrates the fibrillar core structure, allowing productive interaction of aggregated polypeptides with the active site for rapid degradation. The aggregate burden in a cellular model of cytoplasmic tau aggregation is thus reduced. Mechanistic aspects of ATP-independent proteolysis and its implications in amyloid diseases are discussed.

摘要

蛋白质的过度聚集对细胞命运有重大影响,是人类淀粉样变疾病的标志。为了解决不溶性沉积物并维持蛋白质的体内平衡,所有细胞都使用专用的蛋白解聚、蛋白折叠和蛋白降解因子。尽管最近的研究非常深入,但控制这一关键代谢事件的潜在机制还不是很清楚。在这里,我们分析了单一因子——高度保守的丝氨酸蛋白酶 HTRA1 如何以不依赖 ATP 的方式降解淀粉样纤维。这种 PDZ 蛋白酶可溶解蛋白纤维并破坏纤维核心结构,使聚集多肽与活性位点进行有效相互作用,从而快速降解。因此,细胞质 tau 聚集的细胞模型中的聚集体负担减少。讨论了不依赖 ATP 的蛋白水解的机制方面及其在淀粉样变疾病中的意义。

相似文献

1
Determinants of amyloid fibril degradation by the PDZ protease HTRA1.PDZ 蛋白酶 HTRA1 降解淀粉样纤维的决定因素。
Nat Chem Biol. 2015 Nov;11(11):862-9. doi: 10.1038/nchembio.1931. Epub 2015 Oct 5.
2
Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates.人高温需求丝氨酸蛋白酶 A1(HTRA1)降解 tau 蛋白聚集体。
J Biol Chem. 2012 Jun 15;287(25):20931-41. doi: 10.1074/jbc.M111.316232. Epub 2012 Apr 25.
3
HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication.HtrA1 的激活是由单体间变构通讯机制驱动的。
Sci Rep. 2017 Nov 1;7(1):14804. doi: 10.1038/s41598-017-14208-z.
4
An allosteric HTRA1-calpain 2 complex with restricted activation profile.具有受限激活特性的别构 HTRA1-钙蛋白酶 2 复合物。
Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2113520119. doi: 10.1073/pnas.2113520119. Epub 2022 Mar 29.
5
Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3.人HtrA1和HtrA3的PDZ结构域的结构与功能分析
Protein Sci. 2007 Nov;16(11):2454-71. doi: 10.1110/ps.073049407.
6
Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.丝氨酸蛋白酶HtrA1积聚在角膜转化生长因子β诱导蛋白(TGFBIp)淀粉样沉积物中。
Mol Vis. 2013 Apr 12;19:861-76. Print 2013.
7
Proteomic Analysis of Amyloid Corneal Aggregates from TGFBI-H626R Lattice Corneal Dystrophy Patient Implicates Serine-Protease HTRA1 in Mutation-Specific Pathogenesis of TGFBIp.TGFBI-H626R 格子状角膜营养不良患者的淀粉样角膜聚集物的蛋白质组学分析表明丝氨酸蛋白酶 HTRA1 参与 TGFBIp 的突变特异性发病机制。
J Proteome Res. 2017 Aug 4;16(8):2899-2913. doi: 10.1021/acs.jproteome.7b00188. Epub 2017 Jul 20.
8
Implications of the serine protease HtrA1 in amyloid precursor protein processing.丝氨酸蛋白酶HtrA1在淀粉样前体蛋白加工过程中的影响。
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6021-6. doi: 10.1073/pnas.0501823102.
9
Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations.使用力场、半经验和密度泛函理论计算评估淀粉样蛋白β和tau 蛋白肽序列的淀粉样形成倾向。
Int J Mol Sci. 2021 Mar 23;22(6):3244. doi: 10.3390/ijms22063244.
10
Substrate-induced remodeling of the active site regulates human HTRA1 activity.底物诱导的活性位点重构调节人 HTRA1 活性。
Nat Struct Mol Biol. 2011 Mar;18(3):386-8. doi: 10.1038/nsmb.2013. Epub 2011 Feb 6.

引用本文的文献

1
N-acetyl-l-leucine lowers pS129-synuclein and improves synaptic function in models of Parkinson's disease.在帕金森病模型中,N-乙酰-L-亮氨酸可降低pS129-突触核蛋白水平并改善突触功能。
Res Sq. 2025 Apr 9:rs.3.rs-6298077. doi: 10.21203/rs.3.rs-6298077/v1.
2
High resolution analysis of proteolytic substrate processing.蛋白水解底物加工的高分辨率分析
J Biol Chem. 2024 Nov;300(11):107812. doi: 10.1016/j.jbc.2024.107812. Epub 2024 Sep 21.
3
Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease.

本文引用的文献

1
The autolysis of human HtrA1 is governed by the redox state of its N-terminal domain.人HtrA1的自溶作用受其N端结构域氧化还原状态的调控。
Biochemistry. 2014 Jun 17;53(23):3851-7. doi: 10.1021/bi401633w. Epub 2014 Jun 6.
2
Impact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI mice.年龄对野生型和Tg-SwDI小鼠脑血管蛋白质组的影响。
PLoS One. 2014 Feb 26;9(2):e89970. doi: 10.1371/journal.pone.0089970. eCollection 2014.
3
Chaperone machines for protein folding, unfolding and disaggregation.伴侣分子在蛋白质折叠、解折叠和去聚集中的作用。
遗传相关性 HTRA1 蛋白酶活性和循环水平均可独立预测缺血性卒中和冠状动脉疾病风险。
Nat Cardiovasc Res. 2024 Jun;3(6):701-713. doi: 10.1038/s44161-024-00475-3. Epub 2024 May 20.
4
The emerging role of the HTRA1 protease in brain microvascular disease.HTRA1蛋白酶在脑微血管疾病中的新作用。
Front Dement. 2023 Apr 12;2:1146055. doi: 10.3389/frdem.2023.1146055. eCollection 2023.
5
Rational correction of pathogenic conformational defects in HTRA1.理性矫正 HTRA1 的致病构象缺陷。
Nat Commun. 2024 Jul 16;15(1):5944. doi: 10.1038/s41467-024-49982-8.
6
Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.虽已破碎但未被击败:通过降解降低淀粉样蛋白致病性的挑战。
J Adv Res. 2025 Apr;70:45-62. doi: 10.1016/j.jare.2024.04.018. Epub 2024 Apr 19.
7
HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species.HTRA1 可使 α-突触核蛋白淀粉样纤维解聚,并将其转化为无毒且无成核能力的物质。
Nat Commun. 2024 Mar 18;15(1):2436. doi: 10.1038/s41467-024-46538-8.
8
Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease.基因代理的HTRA1蛋白酶活性和循环水平可独立预测缺血性中风和冠状动脉疾病的风险。
Res Sq. 2023 Nov 7:rs.3.rs-3523612. doi: 10.21203/rs.3.rs-3523612/v1.
9
Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.Tau蛋白截短在阿尔茨海默病发病机制中的作用:一篇叙述性综述
Neural Regen Res. 2024 Jun 1;19(6):1221-1232. doi: 10.4103/1673-5374.385853. Epub 2023 Sep 22.
10
Amyloid fibrils degradation: the pathway to recovery or aggravation of the disease?淀粉样纤维降解:疾病恢复或加重的途径?
Front Mol Biosci. 2023 Jun 12;10:1208059. doi: 10.3389/fmolb.2023.1208059. eCollection 2023.
Nat Rev Mol Cell Biol. 2013 Oct;14(10):630-42. doi: 10.1038/nrm3658. Epub 2013 Sep 12.
4
Tau pathology and neurodegeneration.tau 病理学与神经退行性变。
Lancet Neurol. 2013 Jun;12(6):609-22. doi: 10.1016/S1474-4422(13)70090-5.
5
The emerging roles of HTRA1 in musculoskeletal disease.htra1 在肌肉骨骼疾病中的新兴作用。
Am J Pathol. 2013 May;182(5):1482-8. doi: 10.1016/j.ajpath.2013.02.003. Epub 2013 Mar 13.
6
Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients.功能可塑性使 hsp104 能够解聚不同的淀粉样蛋白和非淀粉样蛋白底物。
Cell. 2012 Nov 9;151(4):778-793. doi: 10.1016/j.cell.2012.09.038.
7
NIH Image to ImageJ: 25 years of image analysis.NIH 图像到 ImageJ:25 年的图像分析。
Nat Methods. 2012 Jul;9(7):671-5. doi: 10.1038/nmeth.2089.
8
The spread of neurodegenerative disease.神经退行性疾病的传播
N Engl J Med. 2012 May 31;366(22):2126-8. doi: 10.1056/NEJMcibr1202401.
9
Structural and functional analysis of HtrA1 and its subdomains.HtrA1 及其亚结构域的结构与功能分析。
Structure. 2012 Jun 6;20(6):1040-50. doi: 10.1016/j.str.2012.03.021. Epub 2012 May 10.
10
Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates.人高温需求丝氨酸蛋白酶 A1(HTRA1)降解 tau 蛋白聚集体。
J Biol Chem. 2012 Jun 15;287(25):20931-41. doi: 10.1074/jbc.M111.316232. Epub 2012 Apr 25.